/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Typewriter Therapeutics

Typewriter Therapeutics

Cambridge, United States

Typewriter Therapeutics is building genetic medicines with the potential for durable, curative impact on patients with cancer, autoimmune and severe genetic diseases

Healthcare & Biotech

Typewriter Therapeutics, based in Cambridge, United States, has 2 investors on file, among them AN Venture Partners and RA Capital. Its latest round on record is Series A, 2 Sept 2026. Its site was last checked 6 Nov 2026: site answers.

typewritertx.com

Funding

1 round on record
Latest roundSeries A2 Sept 2026
Since that round2 monthsno later round on record
Investors in its rounds52 with a VCinfo profile
Sept 2026Series ALed by AN Venture Partners, RA Capital, with 3 others

Round sizes and total raised are on Fundup AI, our sister product for funding data.

SEC Form D filings

1 filing
$56.3M sold21 Sept 2026

Filed by Typewriter Therapeutics, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.

Investors

2 investors on file
InvestorEvidenceType
AN Venture PartnersPage + roundVenture capital
RA CapitalPage + roundVenture capital

More from AN Venture Partners

7 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (100%).

City Therapeutics, Inc.City Therapeutics is a clinical-stage biotechnology company developing…Crystalys TherapeuticsCrystalys Therapeutics develops new therapeutics to address unmet medi…ImbriaImbria develops novel treatments for cardiovascular diseases by enhanc…Tortugas NeuroscienceTortugas Neuroscience develops drugs for neurology and neuropsychiatryCapacity BioCapacity Bio develops small molecules, peptides, and nanoparticles to …

See AN Venture Partners' full profile · Who invests alongside it

More from RA Capital

215 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (86%), Industrial & Manufacturing (4%), AI & Machine Learning (2%).

89 Bio, Inc. (Alumni)AN2 TherapeuticsAN2 Therapeutics develops boron-based medicines for various diseases, …ARS PharmaceuticalsARS Pharmaceuticals develops patient-friendly treatments, including a …AbcuroAbcuro develops therapies for autoimmune diseases and cancer.Aclaris TherapeuticsAclaris Therapeutics is a biopharmaceutical company that strives to tr…

See RA Capital's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Typewriter Therapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when AN Venture Partners adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/typewritertx.com/investors

# also
GET /v1/companies/typewritertx.com
GET /v1/companies/typewritertx.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing